To investigate the effects of destabilization of β-catenin and RAS on CSC activation related to metastasis, we subcutaneously implanted NOD/SCID mice with KRAS mutated colon adenocarcinoma metastasized to lung, and measured effect of KYA1797K treatment. This evidence concerns the gene KRAS and colon adenocarcinoma.